Carfilzomib Combined with Thalidomide and Low-Dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma: The Carthadex Trial

Ruth Wester, Bronno van der Holt, Emelie Asselbergs, Sonja Zweegman, Marie Jose Kersten, Edo Vellenga, Marinus van Marwijk Kooij, Okke de Weerdt, Monique C. Minnema, Sarah Lonergan, Antonio Palumbo, Henk M. Lokhorst, Annemiek Broyl, Karim Saad Iskander, Pieter Sonneveld

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Number of pages4
Publication statusPublished - 7-Dec-2017
Event59th Annual Meeting of the American-Society-of-Hematology (ASH) - Atlanta, United States
Duration: 9-Dec-201712-Dec-2017

Cite this